First Time Loading...

Amneal Pharmaceuticals Inc
NYSE:AMRX

Watchlist Manager
Amneal Pharmaceuticals Inc Logo
Amneal Pharmaceuticals Inc
NYSE:AMRX
Watchlist
Price: 5.77 USD -4.63%
Updated: Apr 25, 2024

ROE
Return on Equity

-52.8%
Current
-13%
Average
2.3%
Industry
Negative for the last year
-52.8%
Negative average
-13%
Worse than average
Worse than industry value

ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.

ROE
-52.8%
=
Net Income
-84m
/
Equity
157.1m

ROE Across Competitors

ROE Comparison
Amneal Pharmaceuticals Inc Competitors

Country US
Market Cap 1.8B USD
ROE
-53%
Country JP
Market Cap 776 550.9T JPY
ROE
-441%
Country US
Market Cap 683.6B USD
ROE
49%
Country DK
Market Cap 3.9T DKK
ROE
88%
Country UK
Market Cap 440.4B GBP
ROE
-4%
Country JP
Market Cap 82T JPY
ROE
1%
Country US
Market Cap 352.4B USD
ROE
56%
Country US
Market Cap 326.9B USD
ROE
1%
Country UK
Market Cap 185.4B GBP
ROE
16%
Country CH
Market Cap 183.9B CHF
ROE
28%
Country CH
Market Cap 174.8B CHF
ROE
40%

Profitability Report

View the profitability report to see the full profitability analysis for Amneal Pharmaceuticals Inc.

See Also

Discover More
What is Return on Equity?

ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.

ROE
-52.8%
=
Net Income
-84m
/
Equity
157.1m
What is the ROE of Amneal Pharmaceuticals Inc?

Based on Amneal Pharmaceuticals Inc's most recent financial statements, the company has ROE of -52.8%.